Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has reported a beneficial ownership of 5.00% in Fresenius Medical Care AG, holding 13,447,914 shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 745,718,619 shares of Haleon PLC common stock, representing 8.5% of the class.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.4% of Dole PLC's common stock as of June 30, 2026.

BlackRock, Inc. has updated its Schedule 13G filing, reporting beneficial ownership of 3,852,554 shares of FABRI Net's common stock, representing 10.8% of the class.

BlackRock, Inc. has reported a beneficial ownership of 5.1% of Joby Aviation, Inc.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.4% beneficial ownership in DraftKings Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7.0% of Dyne Therapeutics, Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.2% in Eagle Bancorp Montana Inc. common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 9.0% in Emergent BioSolutions Inc. as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.0% in Energy Vault Holdings, Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 7.2% of Caribou Biosciences, Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 6,636,810 shares, representing 6.6% of Centuri Holdings Inc.'s common stock.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 9.5% of Century Aluminum Co. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.8% in CG Oncology Inc., holding over 6 million shares.

BlackRock, Inc. has updated its Schedule 13G filing, reporting beneficial ownership of 2,339,239 shares of CEVA Inc. common stock, representing 8.4% of the class.

BlackRock, Inc. has updated its Schedule 13G filing, reporting a beneficial ownership of 8.9% in Chipotle Mexican Grill Inc. as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 7.0% of Citizens Financial Services Inc. common stock as of June 30, 2026.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 7.1% of Citizens, Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.4% in Citizens Community Bancorp Inc. as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.2% of Commercial Vehicle Group Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.6% in Comstock Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 7.5% of Corvus Pharmaceuticals Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 56,018,923 shares of Coty Inc. Class A Stock, representing 6.4% of the class, as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.0% of Credit Acceptance Corp's common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 11.5% of American Healthcare REIT Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 161,979 shares, representing 1.8% of the outstanding common stock of Ascent Industries Co.

BlackRock, Inc. has disclosed a beneficial ownership of 2.8% in Alight Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 7.6% of Amplitude, Inc.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 3,182,080 shares, representing 6.8% of the outstanding common stock of Arrivent Biopharma Inc.

BlackRock, Inc. has updated its Schedule 13G filing, reporting a beneficial ownership of 7.4% in Astera Labs Inc. as of June 30, 2026.